TyraTech, Inc.  

(Public, LON:TYR)   Watch this stock  
Find more results for TYR
-0.34 (-4.57%)
Real-time:   10:58AM GMT+1
LON real-time data - Disclaimer
Currency in GBX unless noted
Range     -
52 week 4.25 - 16.00
Open 7.38
Vol / Avg. 0.00/344,993.00
Mkt cap 20.58M*
P/E     -
Div/yield     -
EPS -0.02*
Shares 161.27M
Beta     -
Inst. own     -
Jul 15, 2014
TyraTech Inc Annual Shareholders Meeting
Jul 3, 2014
TyraTech Inc at Proactive Investors One2One Investor Forum - London

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -345.83% -358.82%
Operating margin -318.69% -318.33%
EBITD margin - -310.39%
Return on average assets -145.37% -255.13%
Return on average equity - -
Employees 18 -
CDP Score - -


Suite 275, 5151 McCrimmon Parkway
United States - Map
+1-919-4154300 (Phone)
+1-302-6555049 (Fax)

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance


TyraTech, Inc. is a natural life sciences company. The Company provides develops, manufactures, markets and sells insecticide and parasiticide products for humans and animals. Its products include biocides, head lice and personal repellent. The Company´┐Żs biocide products are used in livestock and the production of animal premises to protect from infectious diseases. It serves in the markets of agriculture, animal health, commercial/institutional, consumer home, human health and public health. Its technology platform is used to target neurological receptors in insects and parasites. It is focused on developing safer natural products with plant essential oils to be used in a variety of pesticidal and parasitic applications.

Officers and directors

Bruno Georges Jactel Chief Executive Officer, Executive Director
Age: 51
Brian Phillips Company Secretary
Alan John Reade Non-Executive Chairman of the Board
Age: 58
Eric Glenn Wintemute Non-Executive Director
Age: 58
James R. Hills Non-Executive Independent Director
Barrington Marshall Riley Senior Non-Executive Independent Director